QPPV.COM KNOWLEDGE ASSESSMENT

GVP Module VIII: When Is a PASS Needed?

Test your understanding of the concepts covered by GVP Module VIII: When Is a PASS Needed?.

Question 1 of 10Pass mark: 80%

Question 1 of 10 An authority requires a non-interventional study as a condition of a marketing authorisation. How should the MAH primarily classify and manage the study?

As a voluntary research project with optional reporting As an imposed PASS and regulatory obligation As routine pharmacovigilance because it is non-interventional As a registry unrelated to pharmacovigilance commitments

Question 2 of 10 Which statement best reflects the principle of proportionality in PASS decision-making?

Every important risk must be investigated through a large PASS The most complex feasible design should always be selected The least burdensome design that is scientifically adequate should be selected Regulatory obligations can be disregarded if a simpler method exists

Question 3 of 10 Which protocol element is especially important when a PASS is intended to answer a comparative-risk question?

A comparator and an approach to addressing confounding A decision not to define the exposed population A commitment to use only spontaneous reports A plan to omit outcome validation

Question 4 of 10 A risk-minimisation educational material was sent to healthcare professionals. What would be the strongest reason to conduct further structured evaluation?

Distribution automatically proves effectiveness The MAH needs to know whether the material changed the intended prescribing or monitoring behaviour The material exists in more than one language Routine adverse-reaction reporting has continued

Question 5 of 10 For an imposed non-interventional PASS, which action is most appropriate before data collection begins?

Register the relevant study information and complete the applicable protocol process Wait until the final report before documenting the study Treat the study as voluntary until the first interim analysis Begin data collection and seek regulatory review only if results are concerning

Question 6 of 10 Which statement about missing information is most consistent with the article?

Any missing information automatically requires a PASS Missing information should be assessed in relation to its importance and whether other methods can resolve it Missing information is relevant only before authorisation A PASS is required whenever the information concerns an important risk

Question 7 of 10 A voluntary PASS was initiated, but a robust external study has conclusively answered its original safety question. What should the MAH do first?

Continue automatically because every initiated PASS must run to completion Reassess whether the voluntary study still provides meaningful scientific value Stop without documentation because the study was voluntary Convert the study into an imposed PASS

Question 8 of 10 Which question is most likely to require an epidemiological PASS rather than relying solely on spontaneous reports?

Whether an individual case contains missing clinical details Whether a suspected signal should receive initial medical review What is the incidence of an adverse event among exposed patients Whether a published article should be included in literature surveillance

Question 9 of 10 Which situation most clearly indicates that a PASS may not be the appropriate first activity?

A need to estimate incidence in an exposed population A missing detail in an individual adverse-reaction report A need to evaluate comparative risk using an appropriate comparator A need to assess risk factors for a clinically important outcome

Question 10 of 10 Which statement best describes an RMP-driven PASS?

It is automatically legally imposed whenever an RMP exists It is linked to a defined safety concern, missing-information gap or risk-minimisation need in the RMP It is limited to studies measuring product sales It replaces routine pharmacovigilance activities

GVP Module VIII: When Is a PASS Needed?

Cookie Settings